MARKET

ADCT

ADCT

Adc Therapeutics Sa
NYSE
1.102
+0.124
+12.71%
Opening 14:43 06/09 EDT
OPEN
0.9802
PREV CLOSE
0.9777
HIGH
1.110
LOW
0.9700
VOLUME
7.20M
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
0.7796
MARKET CAP
140.16M
P/E (TTM)
-0.9855
1D
5D
1M
3M
1Y
5Y
1D
This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday
Benzinga · 1d ago
ADC Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Downgrades ADC Therapeutics to Neutral
Benzinga · 1d ago
ADC Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TipRanks · 1d ago
Weekly Report: what happened at ADCT last week (0601-0605)?
Weekly Report · 1d ago
Assessing ADC Therapeutics (ADCT) Valuation After Pivotal LOTIS-5 Phase 3 ZYNLONTA Trial Results
Simply Wall St · 2d ago
Investors To Watch Out For Oracle, Adobe Earnings Next Week
Seeking Alpha · 3d ago
ADC Therapeutics: 'Sell' LOTIS-5 Underwhelms And Possible Change In Strategy
Seeking Alpha · 3d ago
More
About ADCT
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Webull offers ADC Therapeutics SA stock information, including NYSE: ADCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADCT stock methods without spending real money on the virtual paper trading platform.